Magoola says cancer treatment invention awarded US patent

After publishing the patent, Magoola was asked to submit an approval plan to the United States Food and Drug Administration (US FDA) next month to prepare for clinical trials of the treatment which will begin before the end of this year.

Dr Matthias Magoola says the US Patent and Trademark Office (USPTO) has granted a patent for his invention of the first treatment of cancer using a novel composition of a guided Ribonucleic acid (RNA).